| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $206K | — | +22.6% |
| Cost of Revenue | $283K | — | +1921.4% |
| R&D Expense | $3.0M | — | -35.1% |
| SG&A Expense | $7.2M | — | +26.2% |
| Operating Income | -$10.2M | — | -1.2% |
| Interest Expense | $3.7M | — | +1.5% |
| Net Income | -$12.7M | — | -75.0% |
| EPS (Basic) | -$0.54 | — | +64.0% |
| EPS (Diluted) | -$0.54 | — | +64.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.2M | -39.5% | -44.6% |
| Accounts Receivable | $216K | -7.3% | — |
| Inventory | $500K | -30.7% | -22.1% |
| Current Assets | $33.9M | -24.1% | -10.2% |
| Total Assets | $34.0M | -24.2% | -11.8% |
| Current Liabilities | $55.0M | +2.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.8M | — | +1.9% |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $232K | — | -98.2% |
| Free Cash Flow | -$11.8M | — | +1.9% |
| +115.3% |
| Long-term Debt | $100.3M | -8.5% | -5.0% |
| Total Liabilities | $139.6M | -0.6% | +8.4% |
| Stockholders' Equity | -$105.5M | -10.6% | -17.0% |